ERBB2 and prostate carcinoma: Studies of clinical prostate cancer samples, however, have produced mixed data, failing to firmly establish a relationship between HER2 overexpression and progression to hormone independence (Osman et al, 2001; Shi et al, 2001; Savinainen et al, 2002; Calvo et al, 2003).